Recent research focusing on Semaglutide at a dosage of 40mg is shedding new light on its potential effects. Preliminary findings suggest that this higher dosage may enhance the drug's ability to regulate blood levels, potentially offering improved outcomes for individuals with insulin resistance. Further investigation is underway to fully evaluate